These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 27899372

  • 1. Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis.
    van Daalen EE, Rizzo R, Kronbichler A, Wolterbeek R, Bruijn JA, Jayne DR, Bajema IM, Rahmattulla C.
    Ann Rheum Dis; 2017 Jun; 76(6):1064-1069. PubMed ID: 27899372
    [Abstract] [Full Text] [Related]

  • 2. Antineutrophil cytoplasmic antibody-associated vasculitis and malignancy.
    Wester Trejo MAC, Bajema IM, van Daalen EE.
    Curr Opin Rheumatol; 2018 Jan; 30(1):44-49. PubMed ID: 28957961
    [Abstract] [Full Text] [Related]

  • 3. Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013.
    Rahmattulla C, Berden AE, Wakker SC, Reinders ME, Hagen EC, Wolterbeek R, Bruijn JA, Bajema IM.
    Arthritis Rheumatol; 2015 Dec; 67(12):3270-8. PubMed ID: 26246307
    [Abstract] [Full Text] [Related]

  • 4. Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.
    Heijl C, Harper L, Flossmann O, Stücker I, Scott DG, Watts RA, Höglund P, Westman K, Mahr A, European Vasculitis Study Group (EUVAS).
    Ann Rheum Dis; 2011 Aug; 70(8):1415-21. PubMed ID: 21616914
    [Abstract] [Full Text] [Related]

  • 5. Cyclophosphamide followed by rituximab for aggressive multiple-relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
    Lionaki S, Fragoulis GE, Venetsanopoulou A, Vlachoyiannopoulos P, Boletis JN, Tzioufas AG.
    Clin Exp Rheumatol; 2017 Aug; 35 Suppl 103(1):155-164. PubMed ID: 28134075
    [Abstract] [Full Text] [Related]

  • 6. Disease Activity, Antineutrophil Cytoplasmic Antibody Type, and Lipid Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Wallace ZS, Fu X, Liao K, Kallenberg CGM, Langford CA, Merkel PA, Monach P, Seo P, Specks U, Spiera R, St Clair EW, Zhang Y, Choi H, Stone JH.
    Arthritis Rheumatol; 2019 Nov; 71(11):1879-1887. PubMed ID: 31162829
    [Abstract] [Full Text] [Related]

  • 7. Malignancy is increased in patients with antineutrophil cytoplasmic antibody-associated vasculitis in China.
    Han XY, Li ZY, Zhao MH, Little MA, Chen M.
    Arthritis Res Ther; 2024 May 31; 26(1):113. PubMed ID: 38822382
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H, Lee SM, Manno RL, Seo P, Geetha D.
    Semin Arthritis Rheum; 2015 Aug 31; 45(1):67-9. PubMed ID: 25796088
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rituximab for ANCA-associated vasculitis in the setting of severe infection.
    Gregersen JW, Chaudhry A, Jayne DR.
    Scand J Rheumatol; 2013 Aug 31; 42(3):207-10. PubMed ID: 23286789
    [Abstract] [Full Text] [Related]

  • 13. Variation in the Treatment of Children Hospitalized With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the US.
    James KE, Xiao R, Merkel PA, Weiss PF.
    Arthritis Care Res (Hoboken); 2017 Sep 31; 69(9):1377-1383. PubMed ID: 27813340
    [Abstract] [Full Text] [Related]

  • 14. Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis.
    Faurschou M, Mellemkjaer L, Voss A, Keller KK, Hansen IT, Baslund B.
    Rheumatology (Oxford); 2015 Aug 31; 54(8):1345-50. PubMed ID: 25234661
    [Abstract] [Full Text] [Related]

  • 15. Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis.
    McAdoo SP, Medjeral-Thomas N, Gopaluni S, Tanna A, Mansfield N, Galliford J, Griffith M, Levy J, Cairns TD, Jayne D, Salama AD, Pusey CD.
    Nephrol Dial Transplant; 2019 Jan 01; 34(1):63-73. PubMed ID: 29462348
    [Abstract] [Full Text] [Related]

  • 16. [Recommendations on the use of rituximab for ANCA-associated vasculitis].
    Gause AM, Rubbert-Roth A, Kommission für Pharmakotherapie.
    Z Rheumatol; 2014 Apr 01; 73(3):287-9. PubMed ID: 27039911
    [Abstract] [Full Text] [Related]

  • 17. Effect of Continuous B Cell Depletion With Rituximab on Pathogenic Autoantibodies and Total IgG Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Cortazar FB, Pendergraft WF, Wenger J, Owens CT, Laliberte K, Niles JL.
    Arthritis Rheumatol; 2017 May 01; 69(5):1045-1053. PubMed ID: 28029751
    [Abstract] [Full Text] [Related]

  • 18. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS).
    Bilgin E, Demirci Yıldırım T, Özdemir Ulusoy B, Öğüt TS, Karabacak M, Sadioğlu Çağdaş Ö, Yıldırım R, Güven DC, Akleylek C, Ediboğlu E, Kutu ME, Özgür D, Kardaş RC, Bölek EÇ, Sandal Uzun G, Özsoy Z, Sarıyıldız E, Ayan G, Armağan B, Erden A, Kılıç L, Erbasan F, Alibaz-Öner F, Aşıcıoğlu E, Yazıcı A, Bilge NŞ, Küçük H, Çelik S, Bes C, Akar S, Yılmaz N, Kaşifoglu T, Cefle A, Direskeneli H, Yazısız V, Dizdar Ö, Omma A, Önen F, Karadağ Ö.
    Intern Emerg Med; 2024 Jun 01; 19(4):1025-1034. PubMed ID: 38553624
    [Abstract] [Full Text] [Related]

  • 19. Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.
    Geetha D, Specks U, Stone JH, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Tchao NK, Ikle D, Jepson B, Brunetta P, Fervenza FC, Rituximab for ANCA-Associated Vasculitis Immune Tolerance Network Research Group.
    J Am Soc Nephrol; 2015 Apr 01; 26(4):976-85. PubMed ID: 25381429
    [Abstract] [Full Text] [Related]

  • 20. Brief Report: Menopause and Primary Ovarian Insufficiency in Women Treated for Antineutrophil Cytoplasmic Antibody-Associated Vasculitides.
    Tuin J, Sanders JS, van Beek AP, Hoek A, Stegeman CA.
    Arthritis Rheumatol; 2016 Apr 01; 68(4):986-92. PubMed ID: 27023359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.